OKYO Pharma Announces Purchase of Shares by Chairman

Summary by AI BETAClose X

OKYO Pharma announced that its Chairman, through an entity he beneficially owns, purchased 22,500 ordinary shares at $1.45 per share, increasing his total holding to 10,873,916 shares, representing 20.55% of the issued share capital. This insider buying activity may signal confidence in the company's prospects as it prepares to initiate a global Phase 3 clinical trial for urcosimod in the second half of the year, enrolling approximately 111 patients for neuropathic corneal pain.

Disclaimer*

UK 100

Latest directors dealings